In a regulatory filing, Cadila said in its opinion this particular matter is not likely to have any material impact on the operations and financials of the company.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2Vr7lsZ
via Latest News of India
Post a Comment